13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurochemists
Neurochemists explore the chemical processes that occur in the brain, focusing on how neurotransmitters, hormones, and other chemicals influence brain function and behavior. They investigate how these chemicals are synthesized, released, and regulated within the nervous system, examining their roles in mood regulation, cognition, and motor control. Neurochemistry plays a critical role in understanding disorders such as depression, anxiety, schizophrenia, and Parkinson's disease, all of which involve imbalances in brain chemistry. Neurochemists also study how drugs, both therapeutic and recreational, affect the brain’s chemical environment and contribute to neurological and psychiatric conditions. Their research provides valuable insights into developing more effective medications, targeting specific neurotransmitter systems to treat conditions like epilepsy, bipolar disorder, and addiction. Furthermore, neurochemists study the molecular mechanisms of neurodegenerative diseases, such as Alzheimer's, where protein misfolding and deposition contribute to cognitive decline. Their work in neurochemical signaling and receptor function has significant implications for drug development, as they aim to create more selective, personalized treatments with fewer side effects. Additionally, neurochemists are involved in studying the impact of diet and lifestyle on brain chemistry, which can influence brain aging, cognitive decline, and overall mental health.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States
Title : Transcranial painless neurorehabilitation scalp acupuncture electrical stimulation for neuroregulation of autism spectrum disorder
Zhenhuan Liu, Guangzhou University Chinese Medicine, China
Title : Effects of prenatal androgen exposure on Purkinje cell morphology in the cerebellum of female rats
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States